(Q62109974)

English

Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma

clinical trial

In more languages

Statements

0 references

Phase II Study of Arsenic Trioxide in Relapsed/Refractory Acute Leukemia and Blast Crisis of Chronic Myeloid Leukemia (English)

0 references

medical condition

0 references

0 references

multiple myeloma

0 references

0 references

United States of America

0 references

November 1997

0 references

number of participants

60

0 references

research intervention

arsenic trioxide

0 references

clinical trial phase

phase II clinical trial

0 references

research subject recruitment status

0 references

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q62109974&oldid=1857056563"